Antibodies to M-type phospholipase A2 receptor (PLA2R) and membranous lupus nephritis

American Journal of Kidney Diseases

Volumn 59, Issue 4, 2012, Pages 585-586

  Gunnarsson, Iva ^a   Schlumberger, Wolfgang ^b   Rönnelid, Johan ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Institute of Experimental Immunology   (Germany)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C1Q ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; IMMUNOSUPPRESSIVE AGENT; MEMBRANE PROTEIN; NUCLEOSOME ANTIBODY; PHOSPHOLIPASE A2 RECEPTOR; PHOSPHOLIPASE A2 RECEPTOR TYPE M; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ADULT; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOPATHOGENESIS; KIDNEY BIOPSY; LETTER; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEIN EXPRESSION; SERODIAGNOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; ANTIBODIES, ANTI-IDIOTYPIC; BIOLOGICAL MARKERS; BIOPSY; CASE-CONTROL STUDIES; FEMALE; HUMANS; KIDNEY; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; RECEPTORS, PHOSPHOLIPASE A2; YOUNG ADULT;

EID: 84859002503     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2011.10.044     Document Type: Letter

References (10)

1. Weening JJ, D'Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol. 2004;15(2):241-250. (Pubitemid 38140764)
2. Swaak AJ, Aarden LA, Statius van Eps LW, et al. Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus. Arthritis Rheum. 1979;22(3):226-235. (Pubitemid 9157358)
3. Linnik MD, Hu JZ, Heilbrunn KR, et al. Relationship between anti-double-stranded DNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus. Arthritis Rheum. 2005;52(4):1129-1137.
4. Trendelenburg M, Lopez-Trascasa M, Potlukova E, et al. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis. Nephrol Dial Transplant. 2006;21(11):3115-3121. (Pubitemid 44567082)
5. Grootscholten C, Dieker JW, McGrath FD, et al. A prospective study of anti-chromatin and anti-C1q autoantibodies in patients with proliferative lupus nephritis treated with cyclophosphamide pulses or azathioprine/ methylprednisolone. Ann Rheum Dis. 2007;66(5):693-696. (Pubitemid 46707143)
6. Sjowall C, Zickert A, Skogh T, et al. Serum levels of autoantibodies against C-reactive protein correlate with renal disease activity and response to therapy in lupus nephritis. Arthritis Res Ther. 2009;11(6):R188.
7. Beck LH Jr, Bonegio RG, Lambeau G, et al. M-Type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361(1):11-21.
8. Hofstra JM, Beck LH Jr, Beck DM, et al. Anti-phospholipase A2 receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol. 2011;6(6):1286-1291.
9. Qin W, Beck LH Jr, Zeng C, et al. Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol. 2011;22(6):1137-1143.
10. do Nascimento AP, Viana Vdos S, Testagrossa Lde A, et al. Antibodies to ribosomal P proteins: a potential serologic marker for lupus membranous glomerulonephritis. Arthritis Rheum. 2006;54(5):1568-1572.